Liaw Patricia C, Ito Takashi, Iba Toshiaki, Thachil Jecko, Zeerleder Sacha
Department of Medicine, Division of Hematology & Thromboembolism, David Braley Research Institute, Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton, Canada.
Department of Emergency and Critical Care Medicine and Department of Systems Biology in Thromboregulation, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Blood Rev. 2016 Jul;30(4):257-61. doi: 10.1016/j.blre.2015.12.004. Epub 2015 Dec 31.
Disseminated intravascular coagulation (DIC) is a heterogeneous group of disorders, which manifest as a spectrum of haemorrhage and thrombosis complicating many primary conditions including sepsis, trauma and malignancies. The pathophysiology of this condition is complex. In the recent years there is growing evidence that damage associated molecular patterns (DAMPs) play a crucial role in the pathogenesis of DIC. Upon cell-death and/or cell activation of hematopoietic and parenchymal cells extracellular cell-free DNA as well as DNA binding proteins (e.g. histones and high mobility group box 1 protein [HMGB1]) are released into circulation. This release is a highly regulated process mediated among others by serine proteases, such as factor VII-activating protease (FSAP) and DNase1. Circulating cell-free DNA has been demonstrated to influence primary and secondary hemostasis by inducing platelet aggregation, promoting coagulation activation, inhibition of fibrinolysis and directly interfering with clot stability. In this respect cell-free DNA in tissue as well as released into the circulation after neutrophil activation in the form of neutrophil extracellular traps (NETs) has been shown to be cytotoxic and highly procoagulant. DNA-binding proteins such as histones and HMGB1 are also strongly procoagulant and are involved in the pathogenesis of DIC. The present review gives an overview on how extracellular DNA is released into circulation and the structure of circulating DNA. In addition it summarizes the effect of extracellular DNA and DNA-binding proteins on platelet activation, plasmatic coagulation as well as fibrinolysis.
弥散性血管内凝血(DIC)是一组异质性疾病,表现为一系列出血和血栓形成,是许多原发性疾病(包括败血症、创伤和恶性肿瘤)的并发症。这种疾病的病理生理学很复杂。近年来,越来越多的证据表明,损伤相关分子模式(DAMPs)在DIC的发病机制中起关键作用。在造血细胞和实质细胞发生细胞死亡和/或细胞激活时,细胞外游离DNA以及DNA结合蛋白(如组蛋白和高迁移率族蛋白B1 [HMGB1])会释放到循环系统中。这种释放是一个高度受调控的过程,其中丝氨酸蛋白酶(如因子VII激活蛋白酶 [FSAP] 和脱氧核糖核酸酶1)起介导作用。循环中的游离DNA已被证明可通过诱导血小板聚集、促进凝血激活、抑制纤维蛋白溶解以及直接干扰血凝块稳定性来影响原发性和继发性止血。在这方面,组织中的游离DNA以及以中性粒细胞胞外诱捕网(NETs)形式在中性粒细胞激活后释放到循环中的游离DNA已被证明具有细胞毒性且促凝性很强。组蛋白和HMGB1等DNA结合蛋白也具有很强的促凝性,并参与DIC的发病机制。本综述概述了细胞外DNA如何释放到循环系统以及循环DNA的结构。此外,还总结了细胞外DNA和DNA结合蛋白对血小板激活、血浆凝血以及纤维蛋白溶解的影响。